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 CURRENTOPINION Evaluation of a child with suspected nephrolithiasis
George S. Reusza, Adam Hosszub, and Eva Kisc
Purpose of review
As the incidence of nephrolithiasis in children doubles every 10 years it is becoming a common disease
associated with significant morbidity along with considerable economic burden worldwide. The aim of this
review is to summarize current data on the epidemiology and causes of renal stones in children and to
provide a frame for the first clinical evaluation of a child with suspected nephrolithiasis.
Recent findings
Dietary and environmental factors are the driving force of changing epidemiology. Diagnosis should be
based on medical history, presenting signs, examination, first laboratory and radiological workup.
Ultrasound should be the initial diagnostic imaging performed in pediatric patients while low-dose
computed tomography is rarely necessary for management. Metabolic factors including hypercalciuria,
hypocitraturia, low fluid intake as well as specific genetic diseases should be explored after the resolution
of initial signs and symptoms.
Summary
Appropriate initial evaluation, imaging technique, identification of risk factors and other abnormalities are
essential for early diagnosis and prevention of stone-related morbidity in children with suspected
nephrolithiasis.
Keywords
epidemiology, kidney stones, low-dose computed tomography, metabolic evaluation, nephrolithiasis,
ultrasound, urolithiasis
INTRODUCTION
Nephrolithiasis is the process in which a solid for-
eign body (kidney stone) is formed by precipitation
and aggregation of urine constituents within the
kidney or the urinary tract. Stone formation occurs
if the concentration of a solute surpasses its limit of
solubility and is further facilitated by sites of aggre-





urinary surface of the renal papillae, bacterial or
epithelial debris in the urine. Conditions leading
to increased concentrations of stone forming solutes
or the decrease of the inhibitory activity of urine
promote stone formation [1,4].
Stones breaking loose from the kidney exit
the body in the urine stream passing through
the ureters, the bladder and the urethra. During
the passage they can cause ureter blockage result-






Herein, we will review some new aspects of the
epidemiology of pediatric nephrolithiasis followed
by analysis of the clinical features of acute stone
disease. Signs and symptoms as well as first-line lab
work and radiological approach to the disease will
be discussed.
Detailed metabolic evaluation, medical and uro-
logical management and the aspects of prevention
are beyond the scope of this survey and will be
discussed in the following articles of this issue.
EPIDEMIOLOGY
The occurrence of kidney stone disease shows high
geographical variability due to – among others –
environmental, metabolic, dietary and genetic fac-
tors [7,8].
Nephrolithiasis is rather common in adults.
Over the past decade incidence increased from 4%
to about 9%, with a slight male preponderance (11%
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among men compared with 7% among women).
The increase in the frequency of renal stones has
been linked to the ‘epidemic’ of obesity [7,9,10]. A
study including around 5000 adult stone patients
showed that obesity and weight gain are indepen-
dent risk factors for the development of nephroli-
thiasis in both sexes [11]. In children the occurrence
of pediatric nephrolithiasis is one magnitude lower
than in adults, nevertheless, incidence has been
steadily growing by 6–10% annually in the past
25 years, with an estimated incidence of 36–57
per 100 000 in the United States [12–15]. Signifi-
cantly, the highest increase has been reported in
teenage girls [14]. Although the epidemic of obesity
has reached the pediatric population as well and
parallels the increase in nephrolithiasis [16,17], its
direct relation to nephrolithiasis is less evident than
in adults. Recent pediatric studies do not agree on
this issue [15,18,19
&&
], presumably due to geograph-
ical and ethnical factors among others, moreover
because of the different methodology of individual
surveys. Results from a study in a network of 30
primary care pediatric practices including 110 cases
and 396 matched controls from the United States
[18] and a tertiary center from the United Kingdom
[15] suggested that BMI should not be considered as
a separate risk factor in the development of kidney
stones in children. In contrast, a large epidemiologic
survey from Israel found that the odds ratio for
nephrolithiasis in candidates with a BMI of more
than 30 kg/m2 was 1.7 compared with candidates
with a BMI of 18.5–24.9 kg/m2 [19
&&
]. Thus, the
relationship between increasing prevalence of neph-
rolithiasis and higher body mass should be
explored further.
With increasing occurrence, the number of hos-
pital admissions, emergency department (ED) visits,
surgical interventions and as a consequence, the
economic burden increases as well [20–22,23
&
].
The great geographical variability may be
explained inter alia by environmental factors, such
as arid climate, as well as dietary habits, such as the
extent of salt and fluid intake, diversity of processed
food and animal protein load and of vegetable and
fruit consumption [24,25]. As an example, in the so-
called stone belt in the southeast of the United
States the prevalence of renal stones is 50% higher
than in the northwest [26]. In the Afro-Asian ‘stone
belt’ zone stretching from Morocco over Egypt to
India, Indonesia and the Philippines there is also a
positive correlation between nephrolithiasis preva-
lence and temperature. However, the high fre-
quency of bladder stones in these regions suggests
the role of possible additional factors (e.g. diet,
malnutrition and infections) [27,28].
WHEN SHOULD NEPHROLITHIASIS BE
SUSPECTED?
The typical stone patient’s symptoms are flank pain,
hematuria, nausea and vomiting [25,26,29]. How-
ever, the signs and symptoms are largely dependent
on the localization of the stone, its dimensions, the
degree of consequent obstruction [30] and the age of
the patient [25,26,29]. In particular, young children
do not present with the usual acute onset of flank
pain seen in adults, therefore children are very often
evaluated for other conditions before the diagnosis of
nephrolithiasis is made. A diagnostic pathway for the
identification of nephrolithiasis is shown in Fig. 1.
Pain and accompanying vegetative symptoms
A kidney stone formed at and fixed to the papilla is
usually asymptomatic [29,31
&&
]. In a study from the
United Kingdom, 13% of stones were diagnosed as
accidental findings in asymptomatic patients [15].
In a Canadian report of the 244 unique children
identified by radiological methods [ultrasound or
computed tomography (CT)] to have renal stones,
140 (57%) were symptomatic while the other 104
patients (43%) were asymptomatic [29,31
&&
].
As the stone breaks away from the papilla and
moves down the ureter it may get stuck at one of the
three preformed areas of decreased luminal diame-
ter: the pyelo-ureteral junction, the crossing site of
the iliac vessels or the uretero-vesical junction, caus-
ing obstruction, consequent distension of the uri-
nary tract and abrasion of the mucosa. In the same
study, 32% of patients presented with pain, 13% had
painful gross hematuria and 36% presented with
urinary tract infection [31
&&
].
Due to the conjoined innervation of the gastroin-
testinal, genitourinary and somatic systems, patients
may feel pain in the intestines, groin, bladder or
KEY POINTS
 Dietary and environmental factors are the driving force
of changing epidemiology of nephrolithiasis.
 Family history and medical history should be explored,
focusing on fluid intake as well as on specific
genetic diseases.
 Ultrasound is the cornerstone of radiological imaging
while low-dose computed tomography is rarely
necessary in children.
 Detailed metabolic evaluation and analysis of stones is
necessary after the resolution of initial signs
and symptoms.
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genitalia, further vegetative signs such as nausea and
vomiting frequently accompany the painful colic [32].
Dilatation of the urinary tract due to obstruction
is not an obligatory diagnostic mark of the passage
of a stone. According to a recent study including 248
consecutive patients presenting with ureteral colic,
nearly 11% did not demonstrate any dilatation and
the majority (nearly 71%) had only mild hydro-
nephrosis. Stone diameter was related to the degree
of hydronephrosis, whereas age, sex and stone loca-
tion were not [30]. Smaller stone size and lower
incidence of hydronephrosis could explain the
lower diagnostic accuracy of ultrasound compared
with CT for detecting ureteral stones [30].
Lower incidence of hydronephrosis in the case
of small stones is a matter of debate and may raise
the question whether the symptoms conceivably
result from transient hydronephrosis which cannot
be detected with imaging modalities [33].
Clinical signs are also largely dependent on the
age of the child. The younger a child is the less
characteristic the symptoms are. In infants, irrita-
bility, inconsolable crying, poor feeding, vomiting
and in the case of urinary tract infection, signs and
symptoms of sepsis may occur [25,26,29].
In young children poorly localized (often perium-
bilical or umbilical) abdominal pain, vomiting, diar-
rhea or constipation can be major challenges for the
differential diagnosis. Only older children present
symptoms similar to those seen in adults. The pain
typically begins as waxing and waning flank pain in
the acute phase [5
&
,34]. Ipsilateral genital pain is a
common symptom of distal ureteral stones. As renal
stones not causing obstruction are usually asymptom-
atic, the detection of a nonobstructive stone with
imaging techniques requires consideration of another
etiology of the patient’s symptoms [29,35].
Hematuria
Hematuria can be macroscopic or more commonly
microscopic. In the case of incidentally discovered
asymptomatic stones hematuria may be absent.
Accordingly, using hematuria to predict the pres-
ence of urolithiasis has an accuracy of only 60% and
the absence of hematuria does not rule out urolith-
iasis [7,36].
Microscopic hematuria may precede the appear-
ance of kidney stones by years and is often associ-
ated with hypercalciuria [37
&
,38]. Hypercalciuria is
Suspected urolithiasis based on paent’s history and presentaon: 
Pain, nausea, voming, hematuria 
Perform focused family history, medical history and examinaon,  
Basic laboratory assessment with creanine and urinalysis 
Consider complicaons or mimic: 
Young age, no prior stone, fever, chills, 
 solitary kidney, suspicion of urolithiasis mimic 
No 
History of prior stone 
and low risk for alternave 
diagnosis or complicated  
urolithiasis 
1. Provide symptom relief 
2. Bedside ultrasound 
No history of prior stone, 
but low risk for alternave 
diagnosis or complicated  
urolithiasis 
1. Provide symptom relief 
2. Imaging with ultrasound,  
3. Consult with radiologist 
CT or MRI 
Suspicion of complicated 
nephrolithiasis or other 
dangerous eology 
1. Ultrasound  
2. Consult with radiologist 
CT or MRI 
Infected renal stone 
1. Treat symptoms, fluids, 
anbiocs,  
2. Ultrasound 
3. Consult urology 
CTI or MRI 
Other condion:  
manage accordingly 
Detailed metabolic evaluaon and analysis of stones or fragments  
FIGURE 1. The urolithiasis diagnostic pathway (based on [5&,23&,25,29]).
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considered to be an important contributor to stone
formation; however, individual studies provide very
different prevalence data, ranging from 10 to 50%
[15,39,40,41
&
]. Further, isolated hypercalciuria
without renal stone disease is associated with an
increased frequency of urinary tract infections [42].
Thus, hypercalciuria and stone disease should be
considered among the risk factors for UTI and
should be investigated particularly in patients with




Urinary tract infections may be present in up to 30%
of patients with urolithiasis. Age below 2 years at
diagnosis, the presence of a metabolic risk factors
and size of stone above 5.3 mm are significant risk
factors for infection [43
&
].
Fevers and chills are not common in uncompli-
cated urolithiasis, but if present, should raise con-
cern for an infected stone [25,44].
DIAGNOSTICS
Initial evaluation depends on the situation in which
the stone is discovered and includes laboratory test-
ing and radiological imaging.
Laboratory testing
In the ED laboratory testing and imaging should
focus on the detection of the suspected renal stone
and its eventual acute consequences, such as
obstruction, infection, and occasionally pre and/
or post renal failure [5
&
,25].
A more detailed metabolic evaluation [40,41
&
]
including urine osmolarity, excretion of solutes
such as calcium, sodium, oxalate, urate, citrate,
magnesium, cysteine, urine pH, etc., should take
place after the resolution of the initial violent signs
and symptoms, or in the case of an accidentally
discovered ‘silent’ stone, because in the acute phase
dehydration (due to vomiting) and therapeutic mea-
sures (intravenous fluids with NaCl load) can signif-
icantly influence urinary concentration and
excretion of solutes.
Blood tests
Dehydration due to vomiting can lead to a tran-
sient rise in serum creatinine of prerenal origin
[5
&
,36]. More severe creatinine elevation may be
detected in patients with solitary kidney or cases
with bilateral obstruction (postrenal mechanism)
[45], advanced chronic kidney disease at baseline
(acute on chronic mechanism). Eventually drug-
induced crystal nephropathy may induce serious





further be associated with renal stone disease and




Parameters indicative of inflammation, such as
increment of neutrophil count or C reactive protein,
may help to differentiate complicated urolithiasis
with infection from an uncomplicated stone
[5
&
,29,36]. However, as an increase in neutrophil
count can also be due to a stress reaction, it should
be considered rather as a supplement to clinical
decision-making [36].
Urinalysis
Urinalysis reveals the presence of hematuria. How-
ever, hematuria may be absent in the case of a silent
stone or in a patient with complete obstruction.
Urinary crystals are common in healthy patients.
As the voided urine specimen cools down during
storage on room temperature, the solubility of urine
components decreases leading to in-vitro crystal
formation. Thus, the presence of crystals per se is
insufficient for the diagnosis of urolithiasis. As
exception to the general rule, specific crystal forms
(e.g. cystine) are informative of the metabolic con-
dition leading to stone disease [1]. The presence of
urinary white blood cells under light microscopy, a
positive leukocyte esterase reaction and nitrites on
the test strip are suggestive for urinary tract infec-
tion. However, urolithiasis can cause sterile ureteral
inflammation, thus urinalysis should always be eval-
uated together with clinical symptoms and the




While native abdominal radiography and intrave-
nous urography were the standard methods to
detect urolithiasis and consequent urinary obstruc-
tion in adults as well as in children for decades, with
the arrival of ultrasound and CT diagnostic algo-
rithms have undergone fundamental changes. In
adult urology CT has become the standard for stone
imaging. Low-dose CT scans can now be performed
with a similar or less amount of radiation as plain
radiographs, without the need for intravenous con-
trast [50]. In pediatrics however, both the American
Urological Association and the European Society for
Pediatric Radiology recommend ultrasound as the
initial imaging modality [51,52]. Accordingly,
abdominal radiography is not used routinely in
children anymore. If clinical suspicion of urolithia-
sis is high enough ideally ultrasound is usually
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Indeed, ultrasound evaluation has its limits. In a
pediatric comparative study from 68 renal stones
detected by CT 30 were not recognized by ultra-
sound. Altogether, ultrasound was 66.7% (48.8–
80.8%) sensitive and 97.4% (86.8–99.9%) specific
for detecting stones. However, of the 30 stones not
detected by ultrasound, only three were more than
3 mm according to CT. Thus, in the clinical practice,
ultrasound has high specificity for detecting neph-
rolithiasis in children but only moderate sensitivity
for stones more than 3 mm, where false negatives are
common [54
&
]. The sensitivity of ultrasound can be
enhanced by the color Doppler technique using the
stone-triggered artifact called twinkling artifact. The
twinkling artifact is a mixture of rapidly alternating
red and blue pixels behind a strongly reflective
object (e.g. calculus) resembling turbulent blood
flow. This phenomenon is thought to be secondary
to intrinsic machine ‘noise’ within the color Dopp-





(Fig. 5a and b).
Meanwhile, thanks to continuous technical
progress the radiation burden of CT has also
decreased substantially; however, it is indeed still
not negligible [50]. Thus, there is a constant effort to
FIGURE 3. Staghorn stone filling the pyelum seen in a
cystinuria patient. Please note the marked acoustic shadow.
The pyelum and some of the chalices are markedly dilated.
FIGURE 4. An ureterolith with an acoustic shadow is seen in
the ureter near the ureterovesical junction. As part of the
consequent obstruction, a dilated ureter is visible behind the
bladder.
FIGURE 5. A nonobstructive small stone is shown at the
ureterovesical junction (a). A stone-triggered artifact called
twinkling artifact is seen (in the same patient) with color
Doppler imaging (b).
FIGURE 2. A nonobstructive hyperechogenic renal stone
with acoustic shadow is seen in the pyelum.
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assist clinical diagnostics with appropriate imaging
algorithms [52,53
&
,58] to reduce rates of initial and
overall CT utilization without adversely impacting
downstream care.
Evaluating risk factors of stone formation
The risk factors should be assessed in two steps.
The first examination is intended to support
general orientation. History of underlying structural
abnormalities of the kidney and urinary tract should
be explored together with the history of nephroli-
thiasis in parents and siblings, as the offspring of
renal stone formers may carry several metabolic risk
factors similar to their parents and which are pre-
disposing to stone formation [59]. Further, cystin-
uria and hyperoxaluria may show increased
occurrence in consanguineous families. Perinatal
medical history with focus on prematurity, vitamin
D supplementation, conditions leading to immobi-
lization, dietary habits with special focus on salt and
animal protein intake should be explored, daily





Further questions concerning medical history





,48] and history of recurrent uri-
nary tract infection, especially when caused by a
urease-producing organism, such as Proteus or Kleb-
siella [28,62].
The patient should be examined for the presence
of manifest or latent malabsorptive intestinal dis-
eases and conditions, such as Crohn’s disease, ulcer-
ative colitis and short gut syndrome as they increase
the risk of stone formation [63,64,65
&
].
In a second step, following the resolution of the
acute symptoms a more detailed metabolic evalua-
tion should take place.
While maintaining habitual fluid intake and
dietary habits, a quantitative analysis of urinary
solutes, both promoters and inhibitors of stone
formation, and the assessment of daily fluid and
food intake urine analysis should be performed [66].
The most appropriate method of urine collec-
tion is still a matter of debate. 24-h urine collection
[67] can be achieved in toilet-trained children,
whereas in children who are not toilet-trained the
solute/creatinine ratio in a single spot urine can be
utilized to assess solute excretion. Alternatively, the
use of 12 h urine collection and second morning
sampling or afternoon single spot urine has also
been proposed. Pediatric normal values for the con-
stituents, such as calcium, oxalate and citrate are
available and should be used as reference [67–70].
Using the concentration of urine constituents,
different equations have been constructed to predict
the risk of crystal precipitation [67,71,72
&
]. Further,
laboratory methods to explore the point of super-
saturation and crystal formation have been designed
[73
&
]. However, these are not part of the everyday
clinical practice.
The analysis of stones or fragments of stones
obtained after spontaneous passage or surgical inter-
vention should always be performed. As stone com-
position can change over time, recurrent stones
should always be analyzed as well [66]. The methods
of choice for analysis are radiograph diffraction or
infrared spectroscopy [74]. This can lead directly to
the diagnosis of rare diseases, such as cystinuria or
adenine phosphoribosyl transferase defect.
CONCLUSION
The diagnosis of suspected nephrolithiasis is based
on medical and family history, presenting signs,
physical examination, first laboratory and radiolog-
ical workup. Ultrasound should be the initial diag-
nostic imaging performed in pediatric patients
while low-dose CT is rarely necessary for manage-
ment. Metabolic factors including hypercalciuria,
hypocitraturia, low fluid intake as well as specific
genetic diseases should be explored after the resolu-
tion of initial signs and symptoms.
Acknowledgements
Figs. 2–5 were kindly provided by the Radiologic Division
of the First Department of Pediatrics, Semmelweis Uni-
versity Budapest.
Financial support and sponsorship
The study was supported by NKFI grant 124549 and
131637.
Conflicts of interest
There are no conflicts of interest.
REFERENCES AND RECOMMENDED
READING
Papers of particular interest, published within the annual period of review, have
been highlighted as:
& of special interest
&& of outstanding interest
1. Baumann JM, Affolter B. From crystalluria to kidney stones, some physicochem-
ical aspects of calcium nephrolithiasis. World J Nephrol 2014; 3:256–267.
2.
&&
Evan AP, Coe FL, Lingeman J, et al. Randall’s plaque in stone formers
originates in ascending thin limbs. Am J Physiol Renal Physiol 2018;
315:F1236–F1242.
Based on serial sections of papillary biopsies the authors conclude that plaques
form preferentially in the basement membranes of ascending limbs of Henle,
confirming the prediction of the washdown theory of plaque pathogenesis.
3.
&&
Wiener SV, Ho SP, Stoller ML. Beginnings of nephrolithiasis: insights into the
past, present and future of Randall’s plaque formation research. Curr Opin
Nephrol Hypertens 2018; 27:236–242.
A comprehensive review of the history of Randall’s plaque research.
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index on pediatric urolithiasis. J Pediatr Urol 2015; 11:350e1–350e6.
17. Kuroczycka-Saniutycz E, Porowski T, Protas PT, et al. Does obesity or
hyperuricemia influence lithogenic risk profile in children with urolithiasis?
Pediatr Nephrol 2015; 30:797–803.
18. Kim SS, Luan X, Canning DA, et al. Association between body mass index and
urolithiasis in children. J Urol 2011; 186:1734–1739.
19.
&&
Alfandary H, Haskin O, Davidovits M, et al. Increasing prevalence of nephro-
lithiasis in association with increased body mass index in children: a popula-
tion based study. J Urol 2018; 199:1044–1049.
A large, population based study from Israel documenting an increasing prevalence
of nephrolithiasis in children with a possible association with the increase in BMI
during the same period.
20. Sas DJ, Hulsey TC, Shatat IF, Orak JK. Increasing incidence of kidney stones
in children evaluated in the emergency department. J Pediatr 2010;
157:132–137.
21. González R, Ludwikowski BM. Editorial: Progress in pediatric urology in the
early 21st century. Front Pediatr 2019; 7:349.




Bowen DK, Tasian GE. Pediatric stone disease. Urol Clin North Am 2018;
45:539–550.
The review analyzes – among others – the overall economic burden of nephro-
lithiasis.
24. Fakheri RJ, Goldfarb DS. Ambient temperature as a contributor to kidney
stone formation: implications of global warming. Kidney Int 2011;
79:1178–1185.
25. Rodriguez Cuellar CI, Wang PZT, Freundlich M, Filler G. Educational review:
role of the pediatric nephrologists in the work-up and management of kidney
stones. Pediatr Nephrol 2020; 35:383–397.
26. Marra G, Taroni F, Berrettini A, et al. Pediatric nephrolithiasis: a systematic
approach from diagnosis to treatment. J Nephrol 2019; 32:199–210.
27. Jazayeri SM, Mamaghani ME, Pourmoghaddam A, et al. Need for emergent
studies on dietary factors among infancy nephrolithiasis. Arch Ital Urol Androl
2011; 83:133–135.
28. Soliman NA, Rizvi SAH. Endemic bladder calculi in children. Pediatr Nephrol
2017; 32:1489–1499.
29. Marzuillo P, Guarino S, Apicella A, et al. Why we need a higher suspicion index
of urolithiasis in children. J Pediatr Urol 2017; 13:164–171.
30. Song Y, Hernandez N, Gee MS, et al. Can ureteral stones cause pain without
causing hydronephrosis? World J Urol 2016; 34:1285–1288.
31.
&&
Cassim R, Van Walraven C, Lavallée LT, et al. Systematic radiologic detection
of kidney stones in Canadian children: a new era of asymptomatic stones? J
Pediatr Urol 2019; 15:467e1–467e7.
A study on the incidence of nephrolithiasis in pediatric patients undergoing
abdominal ultrasound or computerized tomography for all indications, showing
that 43% of the stones were asymptomatic, following a benign course with minimal
need for intervention.
32. Shokeir AA. Renal colic: new concepts related to pathophysiology, diagnosis
and treatment. Curr Opin Urol 2002; 12:263–269.
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